Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,027 | -57,892 | -48,274 | -33,281 | -31,810 |
| Depreciation Amortization | 271 | 279 | 275 | 264 | 191 |
| Accounts payable and accrued liabilities | 654 | -1,228 | 17 | 1,062 | 1,001 |
| Other Working Capital | 3,932 | -1,207 | 80 | -512 | -1,077 |
| Other Operating Activity | 6,928 | 8,063 | 4,571 | 2,699 | 1,964 |
| Operating Cash Flow | $-39,242 | $-51,984 | $-43,331 | $-29,768 | $-29,731 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -69 | -145 | -126 | -294 | -704 |
| Investing Cash Flow | $-69 | $-145 | $-126 | $-294 | $-704 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,144 | 413 | 129,450 | 113,946 | 23,675 |
| Financing Cash Flow | $18,144 | $413 | $129,450 | $113,946 | $23,675 |
| Beginning Cash Position | 158,201 | 209,918 | 123,925 | 40,042 | 46,803 |
| End Cash Position | 137,035 | 158,201 | 209,918 | 123,925 | 40,042 |
| Net Cash Flow | $-21,166 | $-51,716 | $85,993 | $83,883 | $-6,761 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,242 | -51,984 | -43,331 | -29,768 | -29,731 |
| Capital Expenditure | -69 | -145 | -126 | -294 | -704 |
| Free Cash Flow | -39,310 | -52,129 | -43,457 | -30,063 | -30,436 |